Types of breast cancer
In addition to the visible
parts of the breast such as nipple and areola, the breast is composed of acini, lobules, ducts and lobes. Acini
are alveoli lined of round clusters of epithelial cells; their role is to secrete the milk. Grouping together,
the acini form the lobules. These "lobes" in turn lead to milk ducts, small canals through which milk is
supplied to the openings of the nipple (lactation).
Pathologically,
there exist different types of breast cancer and each one has a characteristic and evolution of its own. The
therapy is also based on the type of breast cancer. In general, breast cancer is divided into two broad
categories; and each of these categories includes sub-types: non-invasive or in situ cancer, which only
affects the borders of a duct or lobule; and
invasive or infiltrating cancer, which invades the fatty tissue of the breast. Although it can be, invasive
breast cancer does not automatically mean metastatic breast cancer.
Noninvasive or In Situ Breast Cancer
In a non-invasive breast
cancer, cancer cells locate only inside the breast ducts or lobules. Depending on its characteristic (aggressive or not),
carcinoma in situ can be considered as a precancerous tumor. Non-invasive breast cancer includes two sub
categories.
- Intra-ductal
cancer or ductal carcinoma in situ (DCIS) – a
breast cancer is said DCIS if the cancer cells develop within a milk duct of your breast.
Ductal
carcinoma in situ is the most common form of non-invasive breast cancer, representing approximately 80% of
cases. The diagnosis of ductal carcinoma in situ requires sensitive tests such as mammography for
detection. In almost all cases, treatment leads to complete recovery. However, if left untreated, the
cancer can become "invasive", and spread outside the lactiferous ducts.
- Lobular
carcinoma in situ (LCIS), Intralobular Cancer or Lobular Neoplasia -
generally, breast cancer is considered as lobular carcinoma in situ if the cancer cells locate solely in
the lobules. LCIS is responsible for about 10% of non-invasive breast cancer. This type of breast cancer is
often diagnosed before menopause, and often discovered by hazard during diagnosis performed for other
medical problems. Lobular carcinoma in situ is often considered a pre-cancer of the breast instead of a
real breast cancer; however, having it increases your chance of developing invasive breast cancer later in
life. Therefore, it is important to treat it as earlier as possible.
Invasive
cancer
Invasive
Ductal Carcinoma (IDC) or Infiltrating Ductal Carcinoma – this form
of malignant tumor usually starts in the milk ducts, but makes its way out of
the duct tubes and spreads
to neighboring breast tissue. Without treatment, these cancer cells will continue to develop into a malignant
mass in the breast. In complicated cases, these malignant cells can also spread into the lymph nodes and other
remote sites of the body to form other malignancies; this type of cancer is called metastatic breast
cancer.
Depending on
the location of the tumor, the nipple can retract or sometimes produce discharge. In some
women, the breast skin may fold and retract. Invasive ductal carcinoma is the most common type of breast cancer,
representing approximately 70% of cases.
Infiltrating/Invasive Lobular Cancer or
InvasiveLobular
Carcinoma (ILC) - in this
form of breast cancer, cancer cells are developing in the lobules and then pass through the wall of the lobules
to spread into surrounding tissues. Invasive lobular cancer is not characterized by inflammation and is less
tangible and less visible on mammography. Usually, the cancer is manifested by a vague thickening of the breast
tissue, making it often diagnosed late when the tumor reaches a more or less large size.
Lobular
carcinoma (ILC) can develop in two or more sites within the same breast or in both breasts. In addition, it is
often accompanied by metastases to lymph nodes, the gastrointestinal tract and ovaries. Therapeutic decision of
your doctor depends on your age, health status, and biological characteristics of the tumor. Lobular cancers
tend to be less sensitive to chemotherapy. Lobular carcinoma represents the second most common form of breast
cancer; it is account for 5-15% of cases.
Medullary
Carcinoma - medullary
carcinoma of the breast is a rare malignant breast tumor, representing less than 5% of all breast cancers. It is
characterized by a large solid lesion well defined in the breast. The tumor is often diagnosed in women who are
in their late 40s and early 50s, especially women who are genetically at risk of cancer because of mutations in
the BRCA1 (a human tumor suppressor
gene which produces a protein called breast cancer type 1
susceptibility protein). Prognosis
is often better than that of invasive
or infiltrating ductal carcinoma
(IDC); the tumor
does not grow quickly or spread into
lymph nodes outside the breast.
Medullary
carcinoma has a soft and uniform consistency, resembles the medulla, the lower half of the brainstem. Medullary
carcinoma has a predominance of left breast (about 55%) and upper quadrants (more than 65%).
Cystosarcomas
Phyllodes - in this
rare form of breast cancer, the cancer cells invade the stroma, the connective tissue cells of the breast.
This is a solid tumor that can reach a large volume. Even after a successful treatment, the cancer may recur
locally in approximately 20-35% of cases. Metastases occur in 15% of patients. Although rare, lymph node
metastases can occur; in this case, the cancer cells spread through the bloodstream. In the absence of
metastasis, the prognosis is often good.
Mucinous(Colloid) Carcinoma- this type
of cancer is responsible for 2-4% of breast cancer cases. It grows mainly in postmenopausal women. Although slow
growing, the tumor can grow to become a large tumor. In general, mucinous carcinoma has a better prognosis than
infiltrating ductal carcinoma (IDC).
Paget's
disease of the breast (Paget's disease of the nipple)
–
this is a rare tumor that is characterized by a small wound in the form of eczema in the nipple that does not
heal. There may be redness, nipple discharge and crust. In 50% -75% of cases, there is a mass which is palpable.
Paget's disease of the breast is a rare malignant tumor occurs mainly in women over 40 years, accounting for 1%
-4% of breast cancers.
Because the
lesion has a similarity with eczema, Paget's disease of the nipple is often diagnosed late. Its treatment of
choice is surgery: total mastectomy or modified radical mastectomy.
Paget's
disease can also occur also in areas of the vulva and around the anus. However, the disease should not be
confused with Paget’s disease of bone; they are two different medical condition.
Inflammatory Breast Cancer (IBC)
- this type of breast cancer is relatively
rare but fast-growing and aggressive. It is mainly characterized by redness and swelling associated with
warmth in the breast. The skin may also appear pink, reddish purple or bruised. The skin of the breast can
take a texture similar to skin of an orange. It may also be a change in the appearance of the nipple and pain
in the breast. Inflammatory breast cancer is account for about 3% of cases of breast cancer.
Although the
inflammatory breast cancer tends to grow rapidly, the cancer can be difficult to diagnose at the beginning
because its symptoms are similar to those of a breast infection. In addition, it is difficult to treat
inflammatory breast cancer; at diagnosis, the cancer has often already spread into lymph nodes. In contrast to
some types of breast cancer, the prognosis of inflammatory breast cancer is often bad.
Other less common carcinoma:
There are other less common
carcinomas; their frequency combined is less than 1% of breast cancer cases. Some of them include:
- Adenoid
cystic carcinoma
(ACC)
- Juvenile
secretory carcinoma of the
breast
- cribriform carcinoma of the breast
- squamous cell
carcinoma of the breast
Breast
Cancer Breast Cancer Incidence
|